Search Within

Alexander Noor Shoushtari

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (1)
Groups
  1. Advanced Practice Providers (4)
  2. Department of Medicine (4)
  3. Hematologic Malignancies, Division of (4)
  4. Melanoma Disease Management Team (4)
  5. Melanoma and Immunotherapeutics Service (4)
  6. Solid Tumor Oncology Division (4)

More Groups

People
  1. Nana Prempeh-Keteku (3)
  2. Paul Chapman (3)
  3. Yelena Shames (3)
  4. Claire Friedman (2)
  5. Jedd Wolchok (2)
  6. Katherine Panageas (2)

More People

Years
  1. 2022 (1)
  2. 2016 (3)
Publications
  1. Journal of Clinical Oncology (3)
  2. Investigative Ophthalmology & Visual Science (IOVS) (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Association for Research in Vision and Ophthalmology (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Detectability of plasma-derived circulating tumor DNA panel in patients undergoing primary treatment for uveal melanoma
    Journal Article

    Francis, J. H.; Barker, C. A.; Brannon, A. R.; Canestraro, J.; Robbins, M.; Swartzwelder, C. E.; Levine, S.; Law, C.; Berger, M. F.; Shoushtari, A.; more...
    Investigative Ophthalmology & Visual Science (IOVS) (2022)

    Fulltext@MSK | Save
  • Efficacy of nivolumab and ipilimumab (Nivo + Ipi) combination in melanoma patients (pts) treated at a single institution on an expanded-access program (EAP)
    Meeting Abstract

    Shoushtari, A. N.; Navid-Azarbaijani, P.; Friedman, C. F.; Panageas, K.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Campbell, S. C.; Shames, Y.; Prempeh-Keteku, N. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A randomized phase 2 study of trametinib with or without GSK2141795 in patients with advanced uveal melanoma
    Meeting Abstract

    Shoushtari, A. N.; Kudchadkar, R. R.; Panageas, K.; Murthy, R. K.; Jung, M.; Shah, R.; O'Donnell, B.; Khawaja, T. T.; Shames, Y.; Prempeh-Keteku, N. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Toxicity associated with ipilimumab and nivolumab (Ipi plus Nivo) combination therapy in melanoma patients (pts) treated at a single-institution under an expanded-access program (EAP)
    Meeting Abstract

    Friedman, C. F.; Navid-Azarbaijani, P.; Shoushtari, A. N.; Campbell, S. C.; Callahan, M. K.; Momtaz, P.; Prempeh-Keteku, N. A.; Postow, M. A.; Shames, Y.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save